GeneFerm Biotechnology Co Ltd Working Capital to Net Assets Ratio
GeneFerm Biotechnology Co Ltd working capital to net assets ratio. GeneFerm Biotechnology Co Ltd (1796) has a Working Capital to Net Assets ratio of 51.3% as of June 2025. Working capital of NT$407.33 Million (current assets of NT$541.91 Million minus current liabilities of NT$134.58 Million) is measured against net assets of NT$794.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check GeneFerm Biotechnology Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of GeneFerm Biotechnology Co Ltd (2017–2024)
Working capital to net assets ratio of GeneFerm Biotechnology Co Ltd from 2017 to 2024. This chart shows how GeneFerm Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 51.3%, reflecting working capital of NT$407.33 Million against net assets of NT$794.03 Million TWD. See defensive interval ratio of GeneFerm Biotechnology Co Ltd to measure how many days the company can operate on defensive assets alone.
GeneFerm Biotechnology Co Ltd Working Capital to Net Assets Ratio by Year (2017–2024)
GeneFerm Biotechnology Co Ltd working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for GeneFerm Biotechnology Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 1796 current and non-current assets.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 35.2% | NT$277.71 Million | NT$788.18 Million | NT$411.97 Million | NT$134.26 Million | ▲ +12.0 pp |
| 2023 | 23.2% | NT$207.27 Million | NT$892.84 Million | NT$397.13 Million | NT$189.86 Million | ▲ +7.0 pp |
| 2022 | 16.2% | NT$134.32 Million | NT$830.77 Million | NT$373.54 Million | NT$239.22 Million | ▼ -28.5 pp |
| 2021 | 44.7% | NT$334.00 Million | NT$747.66 Million | NT$765.18 Million | NT$431.18 Million | ▼ -61.3 pp |
| 2020 | 105.9% | NT$419.73 Million | NT$396.19 Million | NT$535.58 Million | NT$115.85 Million | ▲ +108.5 pp |
| 2019 | -2.5% | NT$-24.31 Million | NT$954.50 Million | NT$21.69 Million | NT$46.00 Million | ▼ -49.4 pp |
| 2018 | 46.8% | NT$195.13 Million | NT$416.51 Million | NT$283.31 Million | NT$88.17 Million | ▲ +18.1 pp |
| 2017 | 28.8% | NT$90.62 Million | NT$314.95 Million | NT$236.26 Million | NT$145.63 Million | — |